Lifeward (LFWD) Capital Expenditures Growth (1y) (2016 - 2023)
Lifeward (LFWD) Capital Expenditures Growth (1y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | 106.98% |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | -11.95% |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | -47.73% |
| 10 | Lifeward | 10.92 Mn | -499,629.84 | 1.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -71.43% |
| Sep 30, 2022 | -58.82% |
| Jun 30, 2022 | 650.00% |
| Mar 31, 2022 | -66.67% |
| Sep 30, 2021 | -70.69% |
| Jun 30, 2021 | -66.67% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2019 | 40.00% |
| Dec 31, 2018 | 400.00% |
| Sep 30, 2018 | 300.00% |
| Dec 31, 2017 | -95.45% |
| Sep 30, 2017 | -123.08% |
| Jun 30, 2017 | -95.49% |
| Mar 31, 2017 | -92.25% |
| Dec 31, 2016 | -71.05% |
| Sep 30, 2016 | -83.95% |
| Jun 30, 2016 | 1,430.00% |
| Mar 31, 2016 | -65.23% |